In Cheshire and Merseyside alone, 18,000 people are diagnosed with cancer each year, with three quarters now living for one year after their diagnosis. 1 in 2 people will now be diagnosed with cancer at some stage in their lifetime.
Some parts of Cheshire and Merseyside have high cancer incidence and a lower life expectancy than the national average. Our ultimate aim is to tackle variation and improve clinical outcomes for patients across the region.
Cancer survival in the UK continues to improve rapidly. With the introduction of new treatments and diagnostics, better screening and prevention services and innovative research techniques and technology, survival has doubled in the past 40 years.
Cheshire and Merseyside Cancer Alliance has been accredited with “trailblazer” status, allowing us to accelerate our transformation of cancer services. We strive to be the most ambitious and effective Alliance in England.
As part of our £9m National Cancer Transformation fund programme, we are focusing on delivering the National Cancer Strategy:
· Preventing avoidable cancers to reduce incidence
· Achieving earlier diagnosis to improve survival and outcomes
· Delivering high quality modern services to transform treatments and outcomes
· Transforming cancer follow up and implementing the cancer recovery package for all patients
· Improving patient experience of cancer services
· Ensuring single service models are able to deliver best value and care outcomes.
We are concentrating on the following priorities:
By continuing to work closely with partners across Cheshire and Merseyside and supported by strong clinical engagement, the Alliance will continue to drive the transformational change necessary to reduce variation and improve outcomes and experience for the population we serve.
The lead for the Cancer programme is Ann Marr, Chief Executive of SHKT NHS Trust.
Cheshire and Merseyside Cancer Alliance cancer delivery plan - 2018/19
The plan sets out exciting ambitions to focus on quality, patient experience and sustainability in equal measure. In addition to the year one priorities continued under the National Cancer Transformation Fund, we will develop our system leadership including the following areas:
- Clinical quality, assurance and leadership.
- Performance assurance.
- System reconfiguration including a strategic review of MDTs.
- Delivering an active role in the broader Health and Care Partnership.
View the plan pdf here (566 KB) .